Acanthosis nigricanshttps://en.wikipedia.org/wiki/Acanthosis_nigricans
Acanthosis nigricans ni ishara ya kimatibabu inayodhihirishwa na rangi ya kahawia‑mweusi isiyofafanuliwa vizuri, na kuongezeka kwa rangi ya ngozi. Kawaida hupatikana katika mikunjo ya mwili, kama vile mikunjo ya nyuma, shingo, makwapa, kinena, kitovu, paji la uso, na maeneo mengine. Inahusishwa na ugonjwa wa endokrini, hasa upinzani wa insulini na hyperinsulinemia, kama inavyoonekana katika ugonjwa wa kisukari.

○ Sababu
Kwa kawaida hutokea kwa watu walio na umri chini ya miaka 40, inaweza kurithiwa kijenetiki, na huhusishwa na hali za endocrinopathies kama hypothyroidism, akromegali, ugonjwa wa ovari wa polycystic, kisukari kinachostahimili insulini, au ugonjwa wa Cushing.

○ Matibabu - Dawa za OTC
#40% urea cream
☆ AI Dermatology — Free Service
Katika matokeo ya 2022 ya Stiftung Warentest kutoka Ujerumani, kuridhika kwa watumiaji na ModelDerm kulikuwa chini kidogo kuliko na mashauriano ya matibabu ya simu yanayolipishwa.
  • Ni kawaida kwa watu wenye uzito wa kupita kiasi.
  • Rangi nyeusi na mikunjo katika ngozi zote mbili zinaashiria Acanthosis nigricans.
References Acanthosis Nigricans 28613711 
NIH
Acanthosis nigricans ni dalili ya ngozi ya hali ya msingi. Mara nyingi huonekana kwenye mikunjo ya ngozi kama shingo, makwapa, na kinena; inaonekana kama mabaka meusi yenye kingo zisizo wazi. Hali hii kawaida huhusishwa na ugonjwa wa kisukari na upinzani wa insulini, lakini katika hali nadra inaweza kuashiria saratani ya ndani. Inaweza pia kuonekana kutokana na matatizo ya homoni au kwa kutumia dawa maalum kama vile steroids na vidonge vya kudhibiti uzazi.
Acanthosis nigricans is a cutaneous manifestation of an underlying condition. It usually develops in skin folds, such as the back of the neck, axilla, and groin, where it presents as velvety hyper-pigmented patches with poorly defined borders. Acanthosis nigricans is most commonly associated with diabetes and insulin resistance, but rarely it can be a sign of internal malignancy. It can also occur with hormone disorders or with the use of certain medications like systemic glucocorticoids and oral contraceptives.
 Current treatment options for acanthosis nigricans 30122971 
NIH
Acanthosis nigricans (AN) ni hali ya kawaida ya ngozi inayohusishwa na masuala mbalimbali ya afya kama vile ukinzani wa insulini, kisukari, kunenepa kupita kiasi, baadhi ya saratani, matatizo ya homoni, na athari za dawa. Matibabu ya AN yanahusisha kushughulikia chanzo cha msingi cha tatizo la kiafya. Hapo awali, madaktari hukagua dalili za upinzani wa insulini, ambazo ni pamoja na uzito wa kupita kiasi, cholesterol ya juu, shinikizo la damu, na kisukari wa aina ya 2. Madaktari mara nyingi hupendekeza matumizi ya topical retinoids kama chaguo la kwanza la matibabu, ambayo inaweza kusaidia katika kupunguza unene wa ngozi. Hata hivyo, haijatosha kushughulikia kabisa giza la ngozi. Chaguo zingine za matibabu kama salicylic acid, podophyllin, urea, na calcipotriol pia zinahitaji matumizi ya mara kwa mara.
Acanthosis nigricans (AN) is a common dermatologic manifestation of systemic disease that is associated with insulin resistance, diabetes mellitus, obesity, internal malignancy, endocrine disorders, and drug reactions. Treatment of AN primarily focuses on resolution of the underlying disease processes causing the velvety, hyperpigmented, hyperkeratotic plaques found on the skin. Initial considerations for the AN workup include evaluating patients for insulin resistance syndrome characterized by obesity, dyslipidemia, hypertension, and diabetes mellitus type II. For cosmetic treatment, topical retinoids are considered the first-line therapy for insulin-resistant AN by modifying keratinization rate. However, topical tretinoin requires application for long durations and improves hyperkeratosis, but not hyperpigmentation. Topical salicylic acid, podophyllin, urea, and calcipotriol also require frequent application, while TCA peels may provide a faster and less time-intense burden.